Co-administration of low concentrations of matrix metalloproteinase 2, myosin light chain kinase and nitric oxide synthase inhibitors protects heart from ischemia/reperfusion injury
Authors: I. Bil-Lula, G. Sawicki, M. Wozniak, A. Krzywonos-Zawadzka,
Published in: European Society of Cardiology Congress 2017
Publication type: conference